Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report
The clinical consequences of this lean mass loss depend on context
In contrast, patients with diabetes may be more accustomed to long-term medication routines, making adherence more stable
Acute Kidney Injury After Accelerated Dosing of Tirzepatide in a Patient with Multiple Comorbidities: A Case Report
Common GLP-1 side effects often include nausea, constipation, diarrhea, vomiting, reflux, abdominal discomfort, reduced appetite, and fatigue
There is no confirmed date for BALANCE to begin in Medicare Part D, which means coverage after 2027 is uncertain